This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          August 28, 2015

AUGS Home     Membership     Education     Professional Resources     Practice Management    

 



The Bladder Health Week host form is now open!
AUGS
Bladder Health Week events are designed to further educate women on issues related to their pelvic health: Prolapse, incontinence, and other pelvic floor disorders. The educational content of the program gives women the knowledge and confidence they need to evaluate their own pelvic health and address pelvic health issues with their physician.

The host form for Bladder Health Week will be open until Friday, Sept. 4, 2015. All of the details of your event (date, time, and location) must be confirmed before you complete the form. To complete the host form, click here.

Each host site is responsible for funding, planning, publicizing and hosting the event. AUGS created a toolkit to help you plan your event. The toolkit will be sent via email to all hosts in mid-September.

Click here for more information!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




AUGS HIGHLIGHTS


Submit a late breaking abstract for PFD Week 2015 by Sept. 1
AUGS
AUGS accepts abstracts for oral, poster, and video presentations. Work submitted for presentation at this meeting may not have been previously published, and may not have been previously presented at another national Obstetrics and Gynecology (SGS, ACOG, AAGL) or Urology (SUFU, AUA) meeting. Abstracts that have been presented at non-OBGYN or Urology meetings will be accepted for poster presentation only and will not be eligible for prizes. The author must list where and when the research was presented at the bottom of the abstract when submitted. It is acceptable, however, for it to have been presented at an international meeting outside the United States.

Visit https://augs2015.abstractcentral.com/ to access the abstract site.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Submit an abstract now for the PFD Week 2015 Fellows' Forum
AUGS
The Fellows' Forum, part of Fellows' Day at PFD Week 2015, is an opportunity for OB/GYN and Urology Fellows from across the country to meet one another and present their scientific work in a fellows-only podium session.

To present at the Fellows-only podium session, which will be a non-competitive atmosphere, Fellows must submit a written abstract for presentation at this Forum. Abstracts may be different from, or duplicates of those submitted to PFD Week, the AUGS Annual Scientific Meeting, and will be accepted to the Fellows' Forum whether or not they were accepted for presentation the meeting. Abstract submissions will be accepted until September 11.

Submit your abstract today.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Advertisement
SPONSORED CONTENT


Register for AUGS' 36th Annual Meeting, PFD Week 2015!
AUGS
Join AUGS in Seattle from Oct. 13-17 for the premier of PFD Week, an expansion of the successful AUGS Annual Scientific Meeting. With the traditional two and a half days of scientific presentations and an addition of one day of clinical and surgical workshops, PFD Week 2015 is the go-to meeting for healthcare professionals interested in or actively practicing Female Pelvic Medicine and Reconstructive Surgery.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


AUGS Weekly Poll
Question: Do you watch the Virtual Fellows Forums webinars?
ANSWER NOW

Click here to see the results of last week's poll.

Do you have an idea for a poll question? Email your question to info@augs.org to be reviewed by the AUGS Membership Committee.


PRODUCT SHOWCASE
 

ALLERGAN is continuing to research and develop new treatments for urogynecologists and urologists. In fact, that devotion is demonstrated by our considerable investment to address the continuum of care for patients with Overactive Bladder.
 


PHYSICIAN PAYMENT


ICD-10 flexibilities
AUGS
The CMS/AMA July 6, 2015 Joint Announcement and Guidance regarding ICD-10 flexibilities does not mean there is a delay in the implementation of the ICD-10 code set requirement for Medicare or any other organization. Medicare claims with a date of service on or after Oct. 1, 2015, will be rejected if they do not contain a valid ICD-10 code. The Medicare claims processing systems do not have the capability to accept ICD-0 codes for dates of service after Sept. 30, 2015, or accept claims that contain both ICD-9 and ICD-10 codes for any dates of service. Submitters should follow existing procedures for correcting and resubmitting rejected claims.

ICD-10-CM is composed of codes with 3, 4, 5, 6, or 7 characters. Codes with three characters are included in ICD-10-CM as the heading of a category of codes that may be further subdivided by the use of fourth, fifth, sixth or seventh characters to provide greater specificity. A three-character code is to be used only if it is not further subdivided. While diagnosis coding to the correct level of specificity is the goal for all claims, for 12 months after ICD-10 implementation, if a valid ICD-10 code from the right family is submitted, Medicare will process and not audit valid ICD-10 codes.

Many people use the terms "billable codes" and "valid codes" interchangeably. A complete list of the 2016 ICD-10-CM valid code and code titles is posted on the CMS website at https://www.cms.gov/Medicare/Coding/ICD10/2016-ICD-10-CM-and-GEMs.html. The codes are listed in tabular order (the order found in the ICD-10-CM code book). This list should assist providers who are unsure as to whether an additional 4th, 5th, 6th, or 7th character is needed.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


FPMRS ARTICLES


Using the Vibrance Kegel Device with pelvic floor muscle exercise for stress urinary incontinence
Urology
Urinary incontinence is a common and debilitating condition affecting 15 percent of adult population in America and more than one-third of women above the age of 60. Pelvic floor muscle exercises have been the first-line treatment for urinary incontinence since Arnold Kegel introduced them half a century ago. However, studies have shown that approximately 30 percent of women are unable to perform an isolated pelvic floor contraction following written or verbal instruction. Biofeedback was subsequently introduced into clinical practice with the aim of enhancing the effects of PFMEs and improving muscle function.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Non-drug, non-surgical treatment for OAB
Urgent® PC is an option for OAB patients who have failed conservative and drug therapy. To view the product animation: CLICK HERE
Lantheus Proven Success
Discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease.


Urologic applications of botulinum toxin
Cleveland Clinic Journal of Medicine
The neuromuscular blocker botulinum toxin has a wide variety of medical applications, including overactive bladder and neurogenic detrusor overactivity in patients in whom drug therapy fails or is not well tolerated. Botulinum toxin therapy for these conditions has been shown to be safe and effective in several large multicenter randomized controlled trials. Off-label uses in urology include detrusor external sphincter dyssynergia and pelvic pain syndromes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Vitamin D deficiency in postmenopausal women with pelvic floor disorders
Journal of Mid-life Health via PubMed Central
Pelvic floor disorder is a major clinical problem in postmenopausal women. It is a group of disorders, which includes pelvic organ prolapse, urinary incontinence and fecal incontinence. These can occur alone or in combination. The associated symptoms are vaginal bulge or protrusion, involunt percent, which almost doubles as the age of the women increases, with prevalence being 36-49 percent after 60 years of age. The various factors contributing to PFD include multiparity, mode of delivery, instrumental delivery, obesity, collagen defects with menopause being well-known risk factors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of FPMRS News? Click here to visit the FPMRS News archive page.


Impact of fecal incontinence and its treatment on quality of life in women
Journal of Women's Health via PubMed Central
Fecal incontinence is a physically and psychosocially debilitating disorder which negatively impacts quality of life. It bears a significant burden not only on patients but also on their families, caretakers, as well as society as a whole. Even though it is considered a somewhat common condition, especially as women age, the prevalence is often underestimated due to patients' reluctance to report symptoms or seek care. The evaluation and treatment of FI can be also hindered by lack of understanding of the current management options among healthcare providers and how they impact on QOL. This article provides a comprehensive review on the impact of FI and its treatment on QOL in women.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FPMRS NEWSBRIEFS


Comprehensive study of genetic risks for inflammatory bowel disease in African-Americans
Medical Xpress
Researchers at the Johns Hopkins University School of Medicine, along with colleagues at Emory University and Cedars-Sinai, have published in the journal Gastroenterology the first major, in-depth analysis of genetic risk factors of inflammatory bowel disease in African-Americans. The study, "Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans," is an intensive evaluation of the genetics of inflammatory bowel disease in the African-American population.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


How laser vaginal tightening can treat urinary incontinence in women
Health24
New laser procedures to treat stress urinary incontinence became available in South Africa in July 2015. This painless procedure is able to reduce symptoms without the need for invasive surgery and could be the solution many women are looking for. Stress incontinence is the most common type of urinary incontinence in women, Medline Plus explains. It occurs when the pelvic floor muscles or sphincter are no longer strong enough to properly control the flow of urine, resulting in urine leakages. Stress incontinence can vary in severity — some women may only lose a minute amount of urine very occasionally, whilst others suffer much more frequent or severe leakages.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



FPMRS News

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Caitlin McNeely, Senior Editor, 469.420.2692  
Contribute news


Inclusion of advertisements does not constitute AUGS endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the FPMRS News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Aug. 21, 2015
Aug. 19, 2015 blast
Aug. 14, 2015
Aug. 7, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063